Swiss National Bank Ionis Pharmaceuticals Inc Transaction History

Swiss National Bank

$143 Billion
Q2 2024

A detailed history of Swiss National Bank transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Swiss National Bank holds 258,000 shares of IONS stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

258,000

Previous 254,900 1.22%

Holding current value

$10.2 Million

Previous $11 Million 11.29%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$36.45 - $47.7 $112,995 - $147,870	3,100 Added 1.22%	258,000 $12.3 Million
Q1 2024 May 07, 2024	BUY	$42.03 - $53.55 $25,218 - $32,130	600 Added 0.24%	254,900 $11 Million
Q4 2023 Feb 06, 2024	SELL	$43.39 - $51.63 $1.25 Million - $1.49 Million	-28,800 Reduced 10.17%	254,300 $12.9 Million
Q3 2023 Nov 08, 2023	BUY	$38.5 - $47.13 $115,500 - $141,390	3,000 Added 1.07%	283,100 $12.8 Million
Q2 2023 Aug 09, 2023	BUY	$34.73 - $43.33 $145,866 - $181,986	4,200 Added 1.52%	280,100 $11.5 Million
Q1 2023 May 10, 2023	SELL	$33.58 - $41.2 $1.09 Million - $1.34 Million	-32,500 Reduced 10.54%	275,900 $9.86 Million
Q4 2022 Feb 08, 2023	BUY	$37.12 - $46.52 $215,295 - $269,816	5,800 Added 1.92%	308,400 $11.6 Million
Q3 2022 Nov 09, 2022	BUY	$36.54 - $48.66 $120,582 - $160,578	3,300 Added 1.1%	302,600 $13.4 Million
Q2 2022 Aug 09, 2022	SELL	$31.71 - $43.0 $38,052 - $51,600	-1,200 Reduced 0.4%	299,300 $11.1 Million
Q1 2022 May 09, 2022	BUY	$29.88 - $37.04 $633,456 - $785,248	21,200 Added 7.59%	300,500 $11.1 Million
Q4 2021 Feb 08, 2022	SELL	$25.61 - $35.1 $15,366 - $21,060	-600 Reduced 0.21%	279,300 $8.5 Million
Q2 2021 Aug 06, 2021	SELL	$34.54 - $47.25 $7.96 Million - $10.9 Million	-230,459 Reduced 45.16%	279,900 $11.2 Million
Q1 2021 May 07, 2021	BUY	$42.51 - $63.78 $369,837 - $554,886	8,700 Added 1.73%	510,359 $22.9 Million
Q4 2020 Feb 05, 2021	SELL	$45.3 - $60.27 $625,140 - $831,726	-13,800 Reduced 2.68%	501,659 $28.4 Million
Q3 2020 Nov 09, 2020	SELL	$47.45 - $62.95 $616,850 - $818,350	-13,000 Reduced 2.46%	515,459 $24.5 Million
Q2 2020 Aug 05, 2020	BUY	$46.85 - $61.05 $454,445 - $592,185	9,700 Added 1.87%	528,459 $31.2 Million
Q1 2020 May 08, 2020	BUY	$41.6 - $63.4 $4.07 Million - $6.21 Million	97,900 Added 23.26%	518,759 $24.5 Million
Q4 2019 Feb 06, 2020	SELL	$53.85 - $65.27 $1.04 Million - $1.26 Million	-19,300 Reduced 4.38%	420,859 $25.4 Million
Q3 2019 Nov 12, 2019	BUY	$59.06 - $72.15 $676,768 - $826,766	11,459 Added 2.67%	440,159 $26.4 Million
Q2 2019 Aug 02, 2019	BUY	$62.09 - $86.14 $11.8 Million - $16.4 Million	190,600 Added 80.05%	428,700 $27.6 Million
Q1 2019 May 10, 2019	BUY	$52.92 - $81.17 $396,900 - $608,775	7,500 Added 3.25%	238,100 $19.3 Million
Q4 2018 Feb 13, 2019	BUY	$43.37 - $59.54 $507,428 - $696,618	11,700 Added 5.34%	230,600 $12.5 Million
Q3 2018 Nov 08, 2018	BUY	$42.88 - $53.7 $94,336 - $118,140	2,200 Added 1.02%	218,900 $11.3 Million
Q1 2018 May 04, 2018	BUY	$44.08 - $55.05 $215,992 - $269,745	4,900 Added 2.31%	216,700 $9.55 Million
Q4 2017 Feb 07, 2018	BUY	$50.3 - $64.39 $226,350 - $289,755	4,500 Added 2.17%	211,800 $10.7 Million
Q3 2017 Nov 03, 2017	BUY	$45.56 - $59.57 $9.44 Million - $12.3 Million	207,300	207,300 $10.5 Million

Others Institutions Holding IONS

# of Institutions

389

Shares Held

125M

Call Options Held

2.25M

Put Options Held

510K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Ionis Pharmaceuticals Inc Transaction History